Muscular Dystrophy Association Revenue and Competitors

Chicago, IL USA

Location

$366.3M

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Muscular Dystrophy Association's estimated annual revenue is currently $750M per year.(i)
  • Muscular Dystrophy Association's estimated revenue per employee is $681,199
  • Muscular Dystrophy Association's total funding is $366.3M.

Employee Data

  • Muscular Dystrophy Association has 1101 Employees.(i)
  • Muscular Dystrophy Association grew their employee count by 0% last year.

Muscular Dystrophy Association's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
National VP Corporate PartnershipsReveal Email/Phone
3
National VP, Strategic CommunicationsReveal Email/Phone
4
VP ResearchReveal Email/Phone
5
VP, Corporate & Retail PartnershipsReveal Email/Phone
6
VP, Community Event DevelopmentReveal Email/Phone
7
VP, Treasury ServicesReveal Email/Phone
8
VP, Public Policy & AdvocacyReveal Email/Phone
9
VP, ControllerReveal Email/Phone
10
VP, Financial Planning & ReportingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M53-21%N/AN/A
Add Company

What Is Muscular Dystrophy Association?

Families are at the heart of MDA's mission. A caring and concerned group of families started MDA in 1950, and we continue to relentlessly puruse our promise to free families from the life-threatening effects of muscular dystrophy and muscle-debilitating diseases today. Read more about MDA's journey and the progress we've helped make possible.

keywords:N/A

$366.3M

Total Funding

1101

Number of Employees

$750M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Muscular Dystrophy Association News

2021-10-18 - HILA approves access to Translarna™ the first treatment approved for the underlying cause of childhood muscle wasting disease

HILA approves access to Translarna™ the first treatment approved for the underlying cause of childhood muscle wasting disease Mon, Oct 18, 2021 06:00 CET - Decision by the Finnish Pharmaceuticals Pricing Board (HILA) means access for ambulatory patients with nonsense mutation Duchenne muscular ...

2021-08-30 - Muscular Dystrophy Association Kicks Off National Muscular Dystrophy Awareness Month Announcing Access Survey Data, Community Education, and Events

NEW YORK, Aug. 30, 2021 /PRNewswire/ -- September marks "National Muscular Dystrophy Awareness Month," an annual observance that raises awareness and drives critical fundraising for more than 300,000 families across the nation who are living with muscular dystrophy, ALS, and related neuromuscu ...

2021-08-26 - Muscular Dystrophy Association Announces Its Inaugural MDA Takes Vegas Stream-a-thon Labor Day Weekend

NEW YORK, Aug. 26, 2021 /PRNewswire/ -- The Muscular Dystrophy Association (MDA), long known for its innovative approach to fundraising that changed the course of action for many nonprofits, launched its first-ever telethon over five decades ago. Building on MDA's legacy in Las Vegas, the orga ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$418.8M110817%N/A
#2
$204.4M11233%N/A
#3
$727.1M1132-7%N/A
#4
$159.6M11409%N/A
#5
$337.2M11476%N/A